Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
Home › Stocks › Intuitive Surgical, Inc. (ISRG) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Medical Instruments & Supplies
$557.16
-4.47 (-0.80%)10 Quality Stocks Worth Considering Now
Researching Intuitive Surgical (ISRG) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ISRG and similar high-potential opportunities.
Based on our analysis of 42 Wall Street analysts, ISRG has a bullish consensus with a median price target of $575.00 (ranging from $350.00 to $675.00). The overall analyst rating is Strong Buy (8.1/10). Currently trading at $557.16, the median forecast implies a 3.2% upside. This outlook is supported by 22 Buy, 10 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Robbie Marcus at JP Morgan, projecting a 21.2% upside. Conversely, the most conservative target is provided by Rick Wise at Stifel, suggesting a 37.2% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for ISRG.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Apr 24, 2025 | Barclays | Matt Miksic | Overweight | Maintains | $635.00 |
Apr 23, 2025 | RBC Capital | Shagun Singh | Outperform | Maintains | $605.00 |
Apr 23, 2025 | Baird | David Rescott | Outperform | Maintains | $575.00 |
Apr 23, 2025 | Piper Sandler | Adam Maeder | Overweight | Maintains | $575.00 |
Apr 23, 2025 | Evercore ISI Group | Vijay Kumar | In-Line | Maintains | $470.00 |
Apr 23, 2025 | Truist Securities | Richard Newitter | Buy | Maintains | $590.00 |
Mar 18, 2025 | Baird | David Rescott | Outperform | Maintains | $600.00 |
Mar 17, 2025 | Truist Securities | Richard Newitter | Buy | Maintains | $605.00 |
Jan 24, 2025 | JP Morgan | Robbie Marcus | Overweight | Maintains | $675.00 |
Jan 24, 2025 | Raymond James | Jayson Bedford | Outperform | Maintains | $688.00 |
Jan 24, 2025 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $687.00 |
Jan 24, 2025 | Piper Sandler | Adam Maeder | Overweight | Reiterates | $670.00 |
Jan 24, 2025 | Citigroup | Joanne Wuensch | Buy | Maintains | $711.00 |
Jan 24, 2025 | Truist Securities | Richard Newitter | Buy | Maintains | $666.00 |
Dec 18, 2024 | Truist Securities | Richard Newitter | Buy | Maintains | $640.00 |
Dec 11, 2024 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $630.00 |
Dec 11, 2024 | Citigroup | Joanne Wuensch | Buy | Maintains | $640.00 |
Dec 5, 2024 | Stifel | Rick Wise | Buy | Maintains | $610.00 |
Dec 2, 2024 | Morgan Stanley | Cecilia Furlong | Overweight | Upgrade | $650.00 |
Nov 26, 2024 | BTIG | Ryan Zimmerman | Buy | Maintains | $561.00 |
The following stocks are similar to Intuitive Surgical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Intuitive Surgical, Inc. has a market capitalization of $202.00B with a P/E ratio of 82.6x. The company generates $8.71B in trailing twelve-month revenue with a 28.4% profit margin.
Revenue growth is +19.2% quarter-over-quarter, while maintaining an operating margin of +25.7% and return on equity of +16.0%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Develops robotic-assisted surgery technologies.
The company generates revenue primarily through the sales of its da Vinci Surgical Systems and related instruments and accessories, as well as through service and maintenance contracts. By providing advanced surgical solutions, it enables healthcare providers to improve operational efficiency and patient outcomes, thus creating a strong demand for its products.
Intuitive Surgical is a leader in the medical device industry, focusing on minimally invasive procedures across various specialties such as urology, gynecology, and general surgery. Its innovations not only enhance surgical precision but also contribute to reduced healthcare costs, making it a valuable player in the sector.
Healthcare
Medical Instruments & Supplies
15,638
Dr. Gary S. Guthart Ph.D.
United States
2000
Industrial robots, utilized for automated tasks on manufacturing lines, have been in use for decades, highlighting their established role in the manufacturing sector.
The longevity and reliability of industrial robots indicate a stable market. Growth in automation can signal investment opportunities in tech and manufacturing sectors.
Intuitive Surgical's stock dropped after the announcement that CEO Gary Guthart will resign, effective July 1.
CEO transitions can create uncertainty about a company's future direction and leadership stability, impacting investor confidence and stock performance.
Dave Rosa has been promoted to CEO of Intuitive, while Gary Guthart will transition to executive chair. Craig Barratt will take on the role of lead independent director.
Leadership changes can impact company strategy and performance. New CEO appointments often signal shifts in priorities, affecting investor confidence and stock performance.
Intuitive Surgical (ISRG) shares have risen 9.7% over the past month, recovering from a decline of over 30% from a peak of $616 in January.
Intuitive Surgical's recent stock rebound signals potential recovery and investor confidence, indicating a possible buying opportunity after a significant decline.
Intuitive Surgical (ISRG) is currently attracting significant attention from Zacks.com users, indicating potential investor interest and factors influencing its stock performance.
Increased interest in Intuitive Surgical (ISRG) signals potential volatility and opportunity, making it crucial for investors to assess the factors influencing its stock performance.
Stephanie Link, CIO at Hightower, discussed her recent portfolio adjustments during her appearance on CNBC's "Halftime Report."
Stephanie Link's portfolio changes may signal market trends or sector shifts, influencing investor sentiment and potential stock performance.
Based on our analysis of 42 Wall Street analysts, Intuitive Surgical, Inc. (ISRG) has a median price target of $575.00. The highest price target is $675.00 and the lowest is $350.00.
According to current analyst ratings, ISRG has 22 Buy ratings, 10 Hold ratings, and 1 Sell ratings. The stock is currently trading at $557.16. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict ISRG stock could reach $575.00 in the next 12 months. This represents a 3.2% increase from the current price of $557.16. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue primarily through the sales of its da Vinci Surgical Systems and related instruments and accessories, as well as through service and maintenance contracts. By providing advanced surgical solutions, it enables healthcare providers to improve operational efficiency and patient outcomes, thus creating a strong demand for its products.
The highest price target for ISRG is $675.00 from Robbie Marcus at JP Morgan, which represents a 21.2% increase from the current price of $557.16.
The lowest price target for ISRG is $350.00 from Rick Wise at Stifel, which represents a -37.2% decrease from the current price of $557.16.
The overall analyst consensus for ISRG is bullish. Out of 42 Wall Street analysts, 22 rate it as Buy, 10 as Hold, and 1 as Sell, with a median price target of $575.00.
Stock price projections, including those for Intuitive Surgical, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.